Why the study?
What are the optimal cutoffs for BNP and NT-proBNP to diagnose systolic heart failure in patients with impaired kidney function?
What are the optimal cutoffs for BNP and NT-proBNP to diagnose systolic heart failure in patients with impaired kidney function?
BNP and NT-proBNP are elevated in kidney dysfunction even without heart failure, requiring higher cutoffs (300 pg/ml for BNP and 4502 pg/ml for NT-proBNP) for diagnosing systolic heart failure in this population.
Answers are grounded in this paper and cite their sources.
May warrant higher natriuretic peptide cutoffs for SHF diagnosis in CKD; hypothesis-generating and requires prospective validation.
BACKGROUND: The effect of impaired kidney function on B-type natriuretic peptide (BNP) and N-terminal proBNP (NT-proBNP) is vague. This study was performed to examine the effect of kidney dysfunction on the afore-mentioned markers and determine appropriate cutoffs for systolic heart failure (SHF). METHODS: In this cross sectional study adults with estimated glomerular filtration rate (eGFR) <60 ml/min for ≥3 months were identified in consulting clinics from June 2009 to March 2010. SHF was defined as documented by a cardiologist with ejection fraction of < 40% and assessed by New York Heart Association classification (NYHA). Plasma was assayed for creatinine (Cr), BNP and NT-proBNP. RESULTS: A total of 190 subjects were enrolled in the study, 95 with and 95 without SHF. The mean age of patients was 58 (±15) years, 67.4% being males. Mean BNP levels showed a 2.5 fold and 1.5 fold increase from chronic kidney disease (CKD) stage 3 to stage 5 in patients with and without SHF respectively. NT-proBNP levels in non-heart failure group were 3 fold higher in CKD stage 5 compared to stage 3. Mean NT-proBNP levels were 4 fold higher in CKD stage 5 compared to stage 3 in patients with SHF. Optimal BNP and NT-proBNP cutoffs of SHF diagnosis for the entire CKD group were 300 pg/ml and 4502 pg/ml respectively. CONCLUSION: BNP and NT-proBNP were elevated in kidney dysfunction even in the absence of SHF; however the magnitude of increase in NT-proBNP was greater than that of BNP. BNP and NT-proBNP can be useful in diagnosing SHF, nonetheless, by using higher cutoffs stratified according to kidney dysfunction. NT-proBNP appears to predict heart failure better than BNP.
No takes yet. Share an insight, caveat, or question.
Jafri et al. (2013) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: